✦ LIBER ✦

Anti-hepatitis B virus drugs in clinical and preclinical development

✍ Scribed by Gui-feng Wang; Li-ping Shi; Jian-ping Zuo

Book ID: 107635986
Publisher: SP Wuhan Institute of Virology, CAS
Year: 2008
Tongue: English
Weight: 124 KB
Volume: 23
Category: Article
ISSN: 1674-0769
DOI: 10.1007/s12250-008-2945-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunoglobulin isotypes of anti-HBc and

Immunoglobulin isotypes of anti-HBc and anti-HBe and hepatitis B virus (HBV) DNA elimination in acute hepatitis B

✍ Matti Sällberg; Helen Norder; Ola Weiland; Lars Magnius 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 773 KB

Antibodies to hepatitis B core antigen (anti-HBc) and e antigen (anti-HBe) were assayed in 46 sera from ten patients with acute hepatitis B utilizing immunoglobulin class-and subclass-specific enzyme immunoassays (EIAs). The sera were sampled 1 to 512 days after onset of hepatic symptoms. Four patie

Development and application of an in vit

Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics

✍ Pietro Lampertico; James S. Malter; Michael A. Gerber 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 592 KB

The development of effective anti-hepatitis B virus agents has been hampered by the lack of reliable in uitro systems for the screening of new therapeutics. In an effort to circumvent this problem, we have developed an in uitro system for screening antihepatitis B virus drugs using hepatitis B virus

Molecular and clinical characteristics o

Molecular and clinical characteristics of hepatitis B virus in Korea

✍ Sang Hoon Ahn; Lilly Yuen; Kwang-Hyub Han; Margaret Littlejohn; Hye Young Chang; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

## Abstract Korea is an endemic area of hepatitis B virus (HBV) infection but very little is known about the molecular characteristics of HBV isolates from Korean patients or the association with disease progression. The complete HBV genome sequences from 53 Korean patients with chronic hepatitis B

Hepatitis B and D Virus Infection Among

Hepatitis B and D Virus Infection Among Drug Abusers in Taiwan

✍ M.D. Shou-Dong Lee; Jiin-Yu Wang; Jaw-Ching Wu; Yang-Te Tsai; Kwang-Juei Lo; Yin 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB 👁 1 views

Approximately 15 to 20% of the general population in Taiwan are chronic hepatitis B surface antigen (HBsAg) carriers. However, the incidence of hepatitis D virus (HDV) infection is low (5-8%) in patients with HBsAg-positive chronic liver diseases in this area. To evaluate the prevalence of hepatitis

Preclinical and clinical evaluation of e

Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies

✍ Leonard, J P; Goldenberg, D M 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 157 KB

Detection of hepatitis B virus DNA in se

Detection of hepatitis B virus DNA in serum and relation with the IgM class anti-HBc titers in hepatitis B virus infection

✍ T. J. M. van Ditzhuijsen; G. C. M. Selten; A. M. van Loon; G. Wolters; L. Matthy 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB 👁 2 views

Sera from four groups of patients with different serologic markers of HBV infection were examined for HBV DNA using molecular hybridization technique and for IgM class anti-HBc using an ELISA based on the antibody capture principle. Results of HBV DNA assay were generally in good agreement with the